An interventional study of Incentive letter for pneumococcal vaccination to the patient and to the GP in Chronic Heart Failure, sponsored by University Hospital, Montpellier. Active, not recruiting at 1 site in France. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2024-04-11.
Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Prevention
Heart failure affects more than 1.5 million people in France, resulting in over 70,000 deaths and more than 165,000 hospitalizations each year. Viral and bacterial infections are frequently associated with episodes of acute heart failure in patients with chronic heart failure (CHF). Lower respiratory tract infections, such as influenza and pneumococcus, are common causes of hospitalization for decompensated heart failure, leading to increased morbidity and mortality. Studies have shown that pneumococcal vaccination can reduce the risks of heart attack or stroke in patients with heart failure. However, despite vaccination recommendations, coverage rates remain low, especially for pneumococcus. In this study, we will evaluate the impact of an incentive letter for pneumococcal vaccination on one-year hospitalization rate in patients with heart failure.
5,701 studies on the registry are indexed under Heart Failure; 1,219 are open to participants now.
This study's planned enrollment of 12,000 is above the median of 72 across 3,733 interventional studies indexed under Heart Failure.
Browse Heart Failure studies →University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
-None
Other: Incentive letter for pneumococcal vaccination to the patient and to the GP
Incentive letter for pneumococcal vaccination to the patient and to the GP
1-year Pneumococcus vaccination rate
Time frame: at 1-year
1-year all-cause hospital admission rate
Time frame: at 1-year
1-year specific hospital admission rate
Time frame: at 1-year
1-year all-cause mortality rate
Time frame: at 1-year
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Montpellier